ZURICH (Reuters) - Japan's health ministry has approved drug Avastin for the treatment of aggressive brain cancer in Japan, Swiss pharmaceuticals company Roche said on Monday.Avastin is the first new ...
Read more
ZURICH (Reuters) - Swiss drugmaker Roche Holding AG has received Swiss approval for Erivedge, the first medicine for people with advanced forms of basal cell carcinoma, the most common skin ...
Read more
ZURICH (Reuters) - Swiss pharmaceuticals company Roche Holding AG said on Monday the European Medicines Agency has approved its rheumatoid arthritis drug RoActemra to treat children aged two or older ...
Read more
LONDON (Reuters) - There are no benefits from giving patients with severe flu a double dose of Roche's drug Tamiflu, despite calls by some experts for the use of higher ...
Read more
Roche and Eli Lilly are among major life science players in Indiana putting resources behind a public-private research institute that would discover and develop new health innovations.Industry leaders from the ...
Read more
* Potential sales of $35 bln a year over next 10 years - Citigroup* Immunotherapy may be used in up to 60 percent of cancers* Bristol-Myers Squibb and Roche both ...
Read more
NEW YORK, May 15 (Reuters) - Swiss drugmaker Roche Holding AG is exploring a sale of its blood glucose meters business, three people familiar with the matter told Reuters on ...
Read more
ZURICH (Reuters) - Swiss drugmaker Roche hopes data published this week will show it has a viable follow-on product to help fend off cheaper competition for its best-selling cancer drug, ...
Read more
ZURICH (Reuters) - Swiss drugmaker Roche Holding AG said it had teamed up with biotech firm Ascletis to develop and commercialize its investigative drug danoprevir in China for the treatment ...
Read more
ZURICH/LONDON (Reuters) - Swiss drugmaker Roche Holding AG maintained its forecast of rising sales and profit this year after growth in its mainstay cancer medicines.Demand for its flu drug Tamiflu, ...
Read more
April 9 (Reuters) - An experimental drug that spurs the immune system to fight cancer appeared to be safe and demonstrated anti-tumor activity against a variety of cancers in a ...
Read more
ZURICH (Reuters) - Roche Holding AG's Japanese subsidiary Chugai said on Monday that Japanese health regulators have approved a new formulation of its rheumatoid arthritis drug Actemra.Japanese regulators have approved ...
Read more
March 19, 2013 2:33 pm by Kim, Soyoung | 0 Comments
NEW YORK (Reuters) - Roche Holding AG and a buyout group comprising KKR & Co LP and Hellman & Friedman LLC have joined the bidding for Life Technologies Corp, a ...
Read more
ZURICH (Reuters) - Roche said on Monday the European Medicines Agency (EMA) has expanded the approval of its drug Pegasys plus ribavirin for the treatment of chronic hepatitis C virus ...
Read more
BASEL (Reuters) - Roche shareholders overwhelmingly backed its compensation report on Tuesday, suggesting the company has little to fear from tough new legislation to limit executive pay.Roche's AGM in Basel ...
Read more
